| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 7 | +85.71% | +6.34% | +1.81% | +4.52% | +5.36% | — |
| 14d | 7 | +71.43% | +2.17% | +1.59% | +0.58% | +2.87% | — |
| 30d | 7 | +71.43% | +6.07% | +2.82% | +3.25% | +0.84% | — |
| 60d | 7 | +14.29% | -9.40% | +5.61% | -15.01% | -11.56% | — |
| 90d | 7 | +28.57% | -0.12% | +7.59% | -7.71% | -9.88% | — |
| 180d | 7 | +42.86% | -3.53% | +13.80% | -17.33% | -32.68% | — |
| 1y | 7 | +42.86% | +3.55% | +30.17% | -26.63% | -38.93% | — |
| 2y | 7 | +42.86% | +3.87% | +52.73% | -48.86% | -81.85% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| BOLD BOUNDLESS BIO, INC. | PURCHASEGRANT Stock grant | 48,000 | — | — | 48,000 | Jun 15, 2026 | Jun 15, 2026 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 18,000 | — | — | 18,000 | Jun 8, 2026 | Jun 10, 2026 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 2,000,000 | — | — | 2,000,000 | Jan 29, 2026 | Jan 30, 2026 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 18,000 | — | — | 18,000 | Sep 22, 2025 | Sep 24, 2025 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASEGRANT Stock grant | 24,000 | — | — | 24,000 | Jun 23, 2025 | Jun 23, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | SALE | 2,231,381 | — | — | 0 | Feb 3, 2025 | Feb 4, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | PURCHASE | 37,724 | — | — | 37,724 | Feb 3, 2025 | Feb 4, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | PURCHASE | 270,232 | — | — | 307,956 | Feb 3, 2025 | Feb 4, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | SALE | 363,703 | — | — | 0 | Feb 3, 2025 | Feb 4, 2025 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 2,500,000 | — | — | 2,500,000 | Feb 3, 2025 | Feb 5, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | SALE | 5,704 | — | — | 0 | Dec 9, 2024 | Feb 4, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,086 | — | — | 9,086 | Dec 9, 2024 | Feb 4, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,704 | — | — | 5,704 | Dec 9, 2024 | Feb 4, 2025 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASEGRANT Stock grant | 6,610 | — | — | 6,610 | Jun 20, 2024 | Jun 20, 2024 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 632,759 | — | — | 632,759 | Jun 20, 2024 | Jun 21, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 5,128 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 7,326 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 512,820 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 525,274 | — | — | 550,915 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASEGRANT Stock grant | 13,219 | — | — | 13,219 | Mar 27, 2024 | Mar 29, 2024 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 1,500,000 | — | — | 1,500,000 | Feb 5, 2024 | Feb 7, 2024 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE Chairman & CEO | 278,150 | $1.72 | $478.4K | 12,899,360 | Dec 6, 2023 | Dec 6, 2023 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE Chairman & CEO | 721,850 | $1.69 | $1.22M | 12,899,360 | Dec 5, 2023 | Dec 6, 2023 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE Chairman & CEO | 1,000,000 | $2.03 | $2.03M | 19,456,216 | Oct 5, 2023 | Oct 9, 2023 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE Chairman & CEO | 100,000 | $2.75 | $275.0K | 18,396,216 | Jun 8, 2023 | Jun 8, 2023 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE Chairman & CEO | 100,000 | $2.84 | $284.0K | 18,296,216 | Mar 28, 2023 | Mar 28, 2023 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 1,500,000 | — | — | 1,500,000 | Feb 1, 2023 | Feb 2, 2023 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE Chairman & CEO | 60,000 | $3.86 | $231.4K | 20,256,222 | Jan 10, 2023 | Jan 10, 2023 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE Chairman & CEO | 40,000 | $4.99 | $199.6K | 20,196,222 | Dec 14, 2022 | Dec 15, 2022 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 791,000 | — | — | 791,000 | Feb 1, 2022 | Feb 3, 2022 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE See Remarks | 5,135,390 | — | — | 20,156,222 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ERAS ERASCA, INC. | SALE See Remarks | 6,081,233 | — | — | 0 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ERAS ERASCA, INC. | SALE See Remarks | 336,000 | — | — | 0 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ERAS ERASCA, INC. | SALE See Remarks | 112,000 | — | — | 0 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ERAS ERASCA, INC. | SALE See Remarks | 6,162,468 | — | — | 0 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE See Remarks | 5,441,027 | — | — | 11,899,360 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |